Thermo Fisher Scientific Inc (TMO) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally.

Total Assets Chart for Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc (TMO) total assets for FY2025 were USD 110.3B, a 13.4% change from FY2024. Thermo Fisher Scientific Inc's total assets grew from USD 221.7M in 1985 to USD 110.3B in 2025 (49671.3% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 9.8%, 10-year CAGR of 10.5%, 20-year CAGR of 17.7%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$214.46B
Implied Share Price
$580.02
Enterprise Value
$247.30B
Revenue (TTM)
$46.34B
EBITDA
$11.74B
Profit Margin
15.04%
Trailing P/E
31.05
Forward P/E
22.47
Price/Book (MRQ)
3.96
Price/Sales (TTM)
4.63
EV/EBITDA
20.53
EV/Revenue
5.34
Dividend Yield
0.31%
Book Value
$139.75
Free Cash Flow (FY2025)
$6.29B
Free Cash Flow Yield
2.93%

Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.